JNJ-26113100

· Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-26113100, covering 2013-07-01 to 2013-07-01. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis [Phase 2]